GPNMB Antibodies

Santa Cruz Biotechnology features a diverse variety of GPNMB monoclonal antibodies for investigating glycoprotein NMB (GPNMB) in various biological processes. GPNMB monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GPNMB is a type I transmembrane protein that plays a crucial role in cell adhesion, migration, and immune response regulation. GPNMB functions are essential in tissue remodeling processes and have significant implications in cancer and neurodegenerative disorders. Understanding GPNMB expression and activity patterns can provide valuable insights into its potential as a therapeutic target and biomarker. Researchers can utilize specific GPNMB monoclonal antibodies to track protein localization, measure expression levels, and analyze protein-protein interactions. Investigating GPNMB through multiple experimental approaches helps reveal its biological significance and disease associations. GPNMB research supported by Santa Cruz Biotechnology monoclonal antibodies continues to advance our understanding of human health and disease mechanisms.